cs.LGNov 14, 2026

Does Lifestyle Information Improve Hypertension Prediction? A Leakage-Controlled Evaluation on NHANES

Authors: Uriel Benymon

Organizations: Columbia University, New York, NY, USA

Abstract

Does readily available lifestyle information improve machine-learning prediction of hypertension beyond routine demographic and anthropometric data? On NHANES 2017-March 2020, five model families (Logistic Regression, Random Forest, Gradient Boosting, Bagged Decision Trees, and XGBoost) were evaluated with fold-local preprocessing and paired bootstrap confidence intervals. Adding physical activity, alcohol use, smoking, and sleep information showed no consistent detectable improvement in held-out discrimination: every paired ROC-AUC confidence interval included zero, including under a stricter measured-blood-pressure phenotype and without synthetic oversampling. Mean cross-model SHAP rank agreement fell from 0.873 to 0.806 over all encoded columns, but this decline was largely attenuated over the 19 baseline columns shared by both arms (0.873 vs. 0.863), and likewise under both robustness checks; attribution-agreement comparisons across feature sets of different sizes therefore require a matched comparison space. In exploratory analysis of untreated adults (measured-blood-pressure outcome), all five models showed small positive differences, two with unadjusted intervals excluding zero, meriting confirmation. These results do not imply that lifestyle factors are clinically unimportant; within this cohort, the evaluated lifestyle block added little incremental discrimination beyond an already-informative baseline.

Explore similar work

Jun 29, 2026

Accelerometry-Derived Digital Biomarkers for Cardiometabolic Risk: A Population-Representative Tabular Benchmark with Uncertainty Quantification

Structured tabular data dominates clinical medicine, yet existing benchmarks fail to reflect real-world properties like complex survey sampling, demographic oversampling, and subgroup fairness. We introduce the NHANES Accelerometry Cardiometabolic Benchmark, derived from NHANES 2003-2006, comprising 1,381 adults with hip-worn accelerometry, fasting laboratory biomarkers, dietary intake, and anthropometrics. We evaluate three tabular learning methods -- ridge regression, XGBoost, and the foundation model TabPFN v2 -- to predict glycated haemoglobin (HbA1c), fasting triglycerides, and C-reactive protein (CRP) from activity phenotypes and lifestyle covariates. TabPFN v2 achieves the best overall performance (HbA1c R^2=0.156, CRP R^2=0.383), while triglycerides remain largely unpredictable (R^2 < 0.05), consistent with known genetic dominance. We apply split conformal prediction to generate distribution-free 90% prediction intervals and evaluate demographic coverage equity across sex and race/ethnicity subgroups. Marginal coverage aligns with the 90% target for CRP and HbA1c but falls below for triglycerides. At the subgroup level, we observe localized undercoverage (e.g., HbA1c for Mexican American participants), illustrating the gap between marginal guarantees and the conditional coverage required for clinical fairness. Code and data are at https://github.com/felizzi/nhanes-accel-cardiometabolic-benchmark.
Oct 14, 2026

Clinically Interpretable Biological Age Estimation Using CatBoost and SHAP with Continuous and Categorical Features from NHANES

Biological age (BA) captures inter-individual variation in physiological aging beyond chronological age (CA). Although machine-learning models have advanced BA estimation, many rely primarily on continuous laboratory biomarkers, and SHapley Additive exPlanations (SHAP) dependence plots are typically interpreted visually. We developed a clinically interpretable machine-learning framework for BA estimation using heterogeneous clinical data from the National Health and Nutrition Examination Survey (NHANES 2011-March 2020, N = 24,983 adults aged >= 18). A CatBoost regression model incorporated 44 demographic, laboratory, physical examination, and lifestyle predictors to estimate CA, defining model-estimated age as BA. SHAP provided multi-level interpretability. Crucially, building on standard visual inspection, we implemented a prespecified automated procedure directly on SHAP dependence plots to quantify feature-value ranges associated with lowest and highest BA contributions, corresponding adjustment magnitudes, and zero-crossing thresholds. Model-estimated BA strongly correlated with CA in held-out testing data (Pearson r = 0.798, P < 0.001). Population-level SHAP identified blood urea nitrogen, serum glucose, vigorous recreational activity, red cell distribution width, and alanine aminotransferase among the leading predictors, with three categorical variables ranking among the top 25. Automated quantitative SHAP analysis mapped predictor-specific ranges, effect sizes, and inflection points, while waterfall plots enabled individual explanations. By extending qualitative visual interpretation to reproducible quantitative metrics across heterogeneous clinical data, this framework enhances transparency and provides a scalable methodological foundation for biological aging research and precision health.
Jul 17, 2026

CardioMeta: Calibrated Multi-Task Prediction of Diabetes, Hypertension, and Cardiovascular Disease Across Population and EHR Data

Cardiometabolic diseases remain among the most persistent drivers of preventable morbidity because diabetes, hypertension, and cardiovascular disease frequently co-occur and share metabolic, vascular, demographic, and behavioral determinants. Existing machine learning studies for chronic disease prediction often emphasize discrimination on a single dataset, while underreporting label leakage, calibration, temporal robustness, external transportability, and subgroup reliability. This paper presents CardioMeta, a calibrated multi-task framework for joint prediction of diabetes, hypertension, and cardiovascular disease across population survey and electronic health record (EHR) data. The study uses NHANES for population-level model development and temporal validation, and MIMIC-IV for EHR-domain evaluation under substantial distribution shift. To reduce circular label reconstruction, the primary analysis excludes disease-defining variables from the corresponding prediction heads, while a full-clinical feature setting is retained only as sensitivity analysis. CardioMeta combines a shared cardiometabolic encoder with disease-specific gated heads and post-hoc probability calibration. In the leakage-reduced temporal validation setting, the model achieved a macro-AUROC of 0.839, macro-AUPRC of 0.536, macro-F1 of 0.614, and expected calibration error of 0.024, with modest but consistent improvements over strong gradient-boosting and neural tabular baselines. External evaluation on MIMIC-IV showed clear degradation under domain shift, while limited fine-tuning partially recovered performance. The findings indicate that the principal value of multi-task cardiometabolic modeling lies not in inflated accuracy, but in reproducible leakage control, calibrated probabilities, and transparent reliability reporting across heterogeneous healthcare data sources.